This goes away when you stop taking it
Human clinical data in this area remain more limited but are broadly consistent with the mechanistic findings observed in animal research
Lack of glutathione contributes to oxidative stress, which plays a key role in lung disease, osteoarthritis, cataracts, glaucoma, chemotherapy, and cancer, as well as Alzheimers disease and Parkinsons disease (Wu et al., 2004)
In one phase 2 study: Pancreatitis was reported in about 0.4% of participants (1 out of 267) Gallbladder issues affected roughly 1.1%, with no cases in the placebo group Heart rhythm changes were reported more often in people taking retatrutide (about 6% compared to 3% with placebo) Liver enzyme increases were rare (around 1%), and overall liver health markers stayed stable over time
Watch the full episode: www.youtube.com/watch?v=GGfrESBX0DQ #GLP1 #Podcast #Compliance #Semaglutide #Tirzepatide | Lengea Law